PubRank

Hsu-Ping Kuo

Author PubWeight™ 27.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008 5.19
2 IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007 4.48
3 KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol Cell 2009 1.85
4 Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma. J Immunother 2005 1.65
5 Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 2008 1.56
6 Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol 2011 1.40
7 Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell 2007 1.35
8 Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther 2004 1.32
9 IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression. Mol Cell 2011 1.32
10 APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest 2011 1.23
11 Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res 2008 1.15
12 IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med 2008 1.07
13 Enhancement of Bik antitumor effect by Bik mutants. Cancer Res 2003 1.03
14 Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein? Am J Transl Res 2010 0.95
15 Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer. Mol Cancer Ther 2012 0.94
16 Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers. Cancer Cell 2013 0.87
17 The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription. Mol Carcinog 2009 0.84